![2-Methylcitric acid l-1-yl)methyl]benzoic acid-d3 ClH/c1-13-12-28-10-9-27(13)18-11-15(17-5-8-23-26(17)2)14-3-6-21-20(19(14)24-18)16-4-7-22-25-16](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M26314_1635976302.gif?v=1635976303)
Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
ClH/c1-13-12-28-10-9-27(13)18-11-15(17-5-8-23-26(17)2)14-3-6-21-20(19(14)24-18)16-4-7-22-25-16
inflammation pathways
InChi: InChI=1S/C32H54N2O14/c35-29-8-9-30(36)34(29)48-31(37)10-12-39-14-16-41-18-20-43-22-24-45-26-27-46-25-23-44-21-19-42-17-15-40-13-11-33-32(38)47-28-6-4-2-1-3-5-7-28/h1-2
Tipranavir was approved by the Food and Drug Administration (FDA) on June 22
PF-06670910
2-Methylcitric acid l-1-yl)methyl]benzoic acid-d3 ClH/c1-13-12-28-10-9-27(13)18-11-15(17-5-8-23-26(17)2)14-3-6-21-20(19(14)24-18)16-4-7-22-25-162 Methylcitric acid (Methylcitric acid) is an endogenous metabolite in the 2 methylcitric acid cycle. 2 Methylcitric acid accumulates in methylmalonic and propionic acidemias and acts as a marker metabolite. 2 Methylcitric acid markedly inhibits ADP stimulated and uncoupled respiration in mitochondria supported by glutamate. Product information CAS Number: 6061 96 7 Molecular Weight: 206. 15 Formula: C7H10O7 Chemical Name: 2 hydroxy 1 methylpropane
US$ 126.92
US$ 164.00
US$ 28.99
US$ 86.21
US$ 42.00
US$ 12.49
US$ 65.00